1 Min Read
Nov 20 (Reuters) - Geron Corp:
* Geron announces first patient dosed in expanded part 1 of imerge clinical trial in myelodysplastic syndromes Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.